|
SIGN-UP NOW!
Click to become a The VoiceAmerica Talk Member for Free!
|
|
|
|
|
|
|
|
|
|
|
|
C. diff. Spores and More
Tuesday at 10 AM Pacific
January 11th 2022: Episode 6 November 9th Annual 2021 C. diff. Conference
|
|
This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.
Episode 6
Group Discussion I ‘Recent Developments in Diagnosis, Treatment, and Prevention of
C. difficile infections In Children.’
GROUP DISCUSSION I Thursday Afternoon
Speakers
Thomas J. Sandora, MD MPH (Speaker) Associate Professor of Pediatrics : PANELIST, Harvard Medical School : Panel Discussion I
Larry Kociolek, MD (Speaker) Attending Physician, Ann & Robert H. Lurie Children’s Hospital
Maribeth Nicholson
|
|
Read more
|
|
|
Tune in
|
|
Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
|
|
|
|
|
|
|
Questions? Comments?
Call In Live!
Call-In
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759
|
|
|
|
|
|
|
|
|
Larry Kociolek, MD
|
|
Dr. Kociolek, MD, Attending Physician at the Ann & Robert H. Lurie Children’s Hospital of Chicago and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, the Medical Director of Infection Prevention and Control at Lurie Children’s whereby he coordinates the surveillance for and prevention of infection-related adverse events and leads administrative efforts to optimize patient and healthcare worker safety. Broadly, Dr. Kociolek’s academic interests are focused on healthcare epidemiology, particularly pediatric Clostridioides difficile infection and infections caused by antibiotic-resistant organisms.
|
|
Read more
|
|
|
Maribeth Nicholson, MD, MPH
|
|
Dr. Nicholson, MD, MPH, Assistant Professor of Pediatrics, Associate Program Director, Pediatric Gastroenterology, Hepatology and Nutrition Fellowship Program. Maribeth R. Nicholson, MD MPH, is an assistant professor of pediatric gastroenterology, hepatology and nutrition at Vanderbilt University Medical Center. a pediatrician, an epidemiologist.
|
|
Read more
|
|
|
Thomas J. Sandora, MD MPH
|
|
Dr. Sandora , MD, MPH is an Associate Professor of Pediatrics at Harvard Medical School and an attending in pediatric infectious diseases at Boston Children’s Hospital, where he has served as the Hospital Epidemiologist and Medical Director of Infection Prevention and Control since 2005. Dr. Sandora’s research interests focus on healthcare-associated infections in children, including epidemiology and prevention of pediatric C. difficile infection. He is a co-author of the IDSA-SHEA Clinical Practice Guidelines for C. difficile infection in adults and children, as well as the SHEA Compendium of strategies to prevent C. difficile infections in acute care hospitals.
|
|
Read more
|
|
|
Ken Blount Ph.D.
|
|
Dr. Blount, Ph. D. CSO at Rebiotix, Inc., a Ferring Company, is a seasoned director of collaborative research programs in biotech, pharma, clinical, and academic research settings, and his scientific expertise includes antibiotics discovery and development, fecal microbiome analysis, translational medical oncology, and RNA-targeting therapeutics. Prior to joining Rebiotix,
Dr. Blount coordinated translational urologic oncology research for the Yale Cancer Center. Previously, he was a co-founder and the Director of Biology at BioRelix, a venture-backed Connecticut biotech that developed new antibiotics to target structured bacterial messenger RNAs. At BioRelix, Dr. Blount led a combined force
|
|
Read more
|
|
|
|
|
|
Connect with VoiceAmerica
|
|
|
|
|
|
|
|
|
